Status:
COMPLETED
Homeopathy as an Adjuvant to Chemotherapy Improves Clinical Outcome in Relapsed Pulmonary Tuberculosis
Lead Sponsor:
NMP Medical Research Institute
Conditions:
Pulmonary Tuberculosis
Eligibility:
All Genders
18-60 years
Phase:
PHASE2
Brief Summary
The purpose of the study is to evaluate the effect of homeopathy as an adjuvant to Anti tuberculosis treatment on sputum conversion, hematological, clinical sign and symptoms of relapsed Pulmonary TB.
Eligibility Criteria
Inclusion
- relapse pulmonary tuberculosis patients with acid-fast bacilli smear positive by microscopy, using ZiehlNieelsen staining as recommended by WHO, unfit for DOTS -
Exclusion
- pregnancy, clinical sign of any concomitant disease such as diabetes mellitus, acute renal failure or infectious disease including TB/HIV and HIV positive, currently or taken any alternative therapies in past 6 months
Key Trial Info
Start Date :
February 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT01242592
Start Date
February 1 2005
End Date
June 1 2008
Last Update
November 17 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NMP medical Research Institute
Jaipur, Rajastha, India